Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
A potassium-sparing diuretic is a medicine that increases sodium and water excretion while reducing potassium loss in urine. These drugs act in the later parts of the nephron, particularly the distal tubule and collecting duct. Their diuretic effect is usually weaker than that of loop or thiazide diuretics. Examples include amiloride, triamterene, spironolactone, and eplerenone.
read more about potassiumsparing diuretic ...Potassium-sparing diuretics are used for high blood pressure, edema, heart failure, and selected conditions involving excess aldosterone. They are commonly combined with a thiazide or loop diuretic to reduce potassium loss. Amiloride also has specialized uses in selected disorders involving epithelial sodium channels or lithium-related water balance. The drug choice depends on the condition, kidney function, potassium level, and other medicines.
Amiloride and triamterene block epithelial sodium channels in the collecting duct. Spironolactone and eplerenone block mineralocorticoid receptors and reduce aldosterone signaling. Both mechanisms decrease sodium reabsorption and reduce the electrical conditions that normally promote potassium secretion. The result is modest diuresis with greater potassium retention than occurs with many other diuretics.
Epithelial sodium-channel blockers include amiloride and triamterene. Mineralocorticoid receptor antagonists include spironolactone and eplerenone. Spironolactone also interacts with androgen and progesterone receptors, while eplerenone is more selective. These groups differ in their approved uses, hormonal effects, interactions, and dosing.
High potassium is the main safety concern and can cause weakness, paralysis, or dangerous heart-rhythm changes. Risk is greater with kidney impairment, dehydration, potassium supplements, potassium-containing salt substitutes, or medicines that also raise potassium. Spironolactone can cause breast tenderness, breast enlargement, menstrual changes, or sexual side effects. Potassium, kidney function, blood pressure, fluid status, and interacting medicines require monitoring.
They reduce potassium loss and can raise the blood potassium level. Excessive elevation is more likely with kidney disease or interacting medicines.
Yes. Spironolactone blocks mineralocorticoid receptors and has potassium-sparing diuretic effects. It also has endocrine effects that differ from those of amiloride or triamterene.
The combination can cause dangerous hyperkalemia and should be used only when specifically prescribed and monitored. Potassium-rich salt substitutes can create the same problem.
Their direct diuretic effect is generally modest. They are frequently combined with another diuretic or used for their aldosterone-blocking benefits.
Therapeutic Uses of Diuretic Agents. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK557838/. Date Accessed August 6, 2026.
Amiloride. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK542303/. Date Accessed August 6, 2026.
Spironolactone. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK554421/. Date Accessed August 6, 2026.
Triamterene Capsules: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fea50328-b3d5-4300-8c67-82cda0a975b7. Date Accessed August 6, 2026.
Eplerenone Tablets: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcd7595f-700f-48ba-bf83-05a995ce0731. Date Accessed August 6, 2026.